ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Louisiana » Neurology

Top Neurology Prescribers in Louisiana

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
TROY BEAUCOUDRAY M.D.

Neurology

9,305

$957K

464
50 are 65+

46%
patients receiving schedule two controlled substances

Avg: 3%

59%
patients receiving schedule three controlled substances

Avg: 7%

14%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

13%
prescriptions for brand name drugs

Avg: 26%

$103
Average prescription price

Avg: $180

MOHAMED HAJMURAD MD

Neurology

5,686

$572K

489
323 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

32%
patients receiving schedule three controlled substances

Avg: 7%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 26%

$101
Average prescription price

Avg: $180

GEORGIA LEA M.D.

Neurology

5,078

$913K

514
419 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

4%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

26%
prescriptions for brand name drugs

Avg: 26%

$180
Average prescription price

Avg: $180

RICHARD ZWEIG M.D.

Neurology

4,844

$621K

278
229 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

20%
prescriptions for brand name drugs

Avg: 26%

$128
Average prescription price

Avg: $180

MICHAEL EHRLICH M.D.

Neurology

4,637

$991K

390
265 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

9%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

32%
prescriptions for brand name drugs

Avg: 26%

$214
Average prescription price

Avg: $180

TERENCE D'SOUZA M.D.

Neurology

4,607

$449K

555
381 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

6%
patients receiving schedule three controlled substances

Avg: 7%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

22%
prescriptions for brand name drugs

Avg: 26%

$98
Average prescription price

Avg: $180

GERARD DYNES MD

Neurology

4,411

$655K

506
412 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

3%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

23%
prescriptions for brand name drugs

Avg: 26%

$148
Average prescription price

Avg: $180

STEVEN ZUCKERMAN MD

Neurology

4,310

$1.23M

415
268 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

6%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

36%
prescriptions for brand name drugs

Avg: 26%

$286
Average prescription price

Avg: $180

WAEL ALABDULKARIM MD

Neurology

4,179

$423K

504
326 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

3%
patients receiving schedule three controlled substances

Avg: 7%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

27%
prescriptions for brand name drugs

Avg: 26%

$101
Average prescription price

Avg: $180

WALTER TRUAX MD

Neurology

4,125

$643K

533
380 are 65+

8%
patients receiving schedule two controlled substances

Avg: 3%

7%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

22%
prescriptions for brand name drugs

Avg: 26%

$156
Average prescription price

Avg: $180

GERALD CALEGAN MD

Neurology

3,993

$790K

465
379 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

4%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

30%
prescriptions for brand name drugs

Avg: 26%

$198
Average prescription price

Avg: $180

KEVIN CALLERAME MD

Neurology

3,906

$909K

422
248 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

9%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

32%
prescriptions for brand name drugs

Avg: 26%

$233
Average prescription price

Avg: $180

MARY MCWILLIAMS M.D.

Neurology

3,679

$377K

157
54 are 65+

54%
patients receiving schedule two controlled substances

Avg: 3%

48%
patients receiving schedule three controlled substances

Avg: 7%

13%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

22%
prescriptions for brand name drugs

Avg: 26%

$102
Average prescription price

Avg: $180

JOSEPH ACOSTA MD

Neurology

3,544

$608K

481
350 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

6%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

25%
prescriptions for brand name drugs

Avg: 26%

$172
Average prescription price

Avg: $180

GURLEEN SIKAND MD

Neurology

3,505

$279K

372
297 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 7%

13%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

21%
prescriptions for brand name drugs

Avg: 26%

$80
Average prescription price

Avg: $180

LEOPOLDO DEALVARE M.D.

Neurology

3,486

$606K

327
246 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

4%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

35%
prescriptions for brand name drugs

Avg: 26%

$174
Average prescription price

Avg: $180

MICHAEL HAPPEL MD

Neurology

3,451

$819K

394
272 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

3%
patients receiving schedule three controlled substances

Avg: 7%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

32%
prescriptions for brand name drugs

Avg: 26%

$237
Average prescription price

Avg: $180

FAYEZ SHAMIEH M.D.

Neurology

3,431

$466K

405
218 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

22%
patients receiving schedule three controlled substances

Avg: 7%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

20%
prescriptions for brand name drugs

Avg: 26%

$136
Average prescription price

Avg: $180

FABIAN LUGO M.D.

Neurology

3,362

$689K

302
225 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

46%
prescriptions for brand name drugs

Avg: 26%

$205
Average prescription price

Avg: $180

MICHAEL PUENTE MD

Neurology

3,318

$573K

467
340 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

5%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

31%
prescriptions for brand name drugs

Avg: 26%

$173
Average prescription price

Avg: $180

TIMOTHY BEST MD

Neurology

3,272

$390K

344
243 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

5%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

23%
prescriptions for brand name drugs

Avg: 26%

$119
Average prescription price

Avg: $180

LISA THIBODEAUX M.D.

Neurology

3,263

$457K

326
215 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

13%
patients receiving schedule three controlled substances

Avg: 7%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

32%
prescriptions for brand name drugs

Avg: 26%

$140
Average prescription price

Avg: $180

ARCHIE MELCHER MD

Neurology

3,182

$587K

377
316 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

4%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

33%
prescriptions for brand name drugs

Avg: 26%

$184
Average prescription price

Avg: $180

STEVEN ATKINS MD

Neurology

3,131

$416K

366
251 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

5%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

19%
prescriptions for brand name drugs

Avg: 26%

$133
Average prescription price

Avg: $180

THOMAS KREFFT MD

Neurology

3,049

$373K

400
333 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

4%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

25%
prescriptions for brand name drugs

Avg: 26%

$122
Average prescription price

Avg: $180

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank